Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw–Schulman syndrome)

Furlan, 2001, Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uremic syndrome: the role of von Willebrand factor‐cleaving protease, Best Pract Res Clin Haematol, 14, 437, 10.1053/beha.2001.0142 Sadler, 2002, A new name in thrombosis, ADAMTS13, Proc Natl Acad Sci USA, 99, 11552, 10.1073/pnas.192448999 Tsai, 2003, Deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura, Arterioscler Thromb Vasc Biol, 23, 388, 10.1161/01.ATV.0000058401.34021.D4 Fujimura, 2002, von Willebrand factor‐cleaving protease and Upshaw–Schulman syndrome, Int J Hematol, 75, 25, 10.1007/BF02981975 Moake, 2002, Mechanisms of disease—thrombotic microangiopathies, N Engl J Med, 347, 589, 10.1056/NEJMra020528 Furlan, 1996, Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis, Blood, 87, 4223, 10.1182/blood.V87.10.4223.bloodjournal87104223 Tsaï, 1996, Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion, Blood, 87, 4235, 10.1182/blood.V87.10.4235.bloodjournal87104235 Furlan, 1998, von Willebrand factor‐cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome, N Engl J Med, 339, 1578, 10.1056/NEJM199811263392202 Tsaï, 1998, Antibodies to von Willebrand factor‐cleaving protease in acute thrombotic thrombocytopenic purpura, N Engl J Med, 339, 1585, 10.1056/NEJM199811263392203 Fujikawa, 2001, Purification of human von Willebrand factor‐cleaving protease and its identification as a new member of the metalloprotease family, Blood, 98, 1662, 10.1182/blood.V98.6.1662 Zheng, 2001, Structure of von Willebrand factor‐cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura, J Biol Chem, 276, 41059, 10.1074/jbc.C100515200 Gerritsen, 2001, Partial amino acid sequence of purified von Willebrand factor‐cleaving protease, Blood, 98, 1654, 10.1182/blood.V98.6.1654 Levy, 2001, Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura, Nature, 413, 488, 10.1038/35097008 Kokame, 2002, Mutations and common polymorphisms in ADAMTS 13 gene responsible for von Willebrand factor‐cleaving protease activity, Proc Natl Acad Sci USA, 99, 11902, 10.1073/pnas.172277399 Motto, 2002, ADAMTS13 mutations identified in familial TTP patients result in loss of von Willebrand factor‐cleaving protease activity, Blood, 100, 15a Kentouche, 2002, Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor‐cleaving protease by infusion of solvent/detergent plasma, Acta Paediatr, 91, 1056, 10.1111/j.1651-2227.2002.tb00099.x Antoine, 2003, ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor‐cleaving protease activity by recombinant human ADAMTS13, Br J Haematol, 120, 821, 10.1046/j.1365-2141.2003.04183.x Schneppenheim, 2003, Von Willebrand factor‐cleaving protease and ADAMTS 13 mutations in childhood TTP, Blood, 101, 1845, 10.1182/blood-2002-08-2399 Assink, 2003, Mutation analysis and clinical implications of von Willebrand factor‐cleaving protease deficiency, Kidney Int, 63, 1995, 10.1046/j.1523-1755.63.6s.1.x Savasan, 2003, ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity, Blood, 101, 4449, 10.1182/blood-2002-12-3796 Matsumoto, 2003, Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw–Schulman syndrome, Blood, 10.1182/blood-2003-06-1796 Pimanda, 2003, Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13, Blood Veyradier, 2001, Specific von Willebrand factor‐cleaving protease in thrombotic microangiopathies: a study of 111 cases, Blood, 98, 1765, 10.1182/blood.V98.6.1765 Veyradier, 2003, Severe deficiency of specific von Willebrand factor‐cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome, J Pediatrics, 142, 310, 10.1067/mpd.2003.79 Deschenes, 2002, Plasma therapy in von Willebrand factor protease deficiency, Pediatr Nephrol, 17, 867, 10.1007/s00467-002-0944-9 Obert, 1999, Estimation of the von Willebrand factor‐cleaving protease in plasma using monoclonal antibodies to vWF, Thromb Haemost, 82, 1382, 10.1055/s-0037-1614779 Zheng, 2003, Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13, J Biol Chem, 278, 30136, 10.1074/jbc.M305331200 Soejima, 2003, ADAMTS13 cysteine‐rich/spacer domains are functionally essential for von Willebrand factor cleavage, Blood, 102, 3232, 10.1182/blood-2003-03-0908 Bernardo, 2003, Peptides from the C‐terminal regions of ADAMTS‐13 specifically block cleavage of ultra‐large von Willebrand factor multimers on the endothelial surface under flow, J Thomb Haemost